What is CBG?
CBG, or cannabigerol, is one of more than 100 cannabinoids found in the Cannabis plant genus. CBG (cannabigerol) is the non-acidic version of CBGA (cannabigerol acid), the parent molecule that produces all cannabinoids found in hemp. Because of this, CBGA is known as the mother of all cannabinoids.
CBG, or cannabigerol, is a minor cannabinoid because it only accounts for about 1% of hemp’s biomass. During growth, CBG is synthesized into other cannabinoids, primarily CBD (cannabidiol) or THC (tetrahydrocannabinol), the two major cannabinoids found in cannabis.
CBG (cannabigerol) is not a controlled substance under the Controlled Substances Act in the United States. It is also not scheduled by the UN Convention of Psychotropic Substances of 1971.
Since CBG is a non-psychoactive cannabinoid, and not a controlled substance here in the US, it makes it much easier to research in trials on humans. Currently, it is being studied for its effects on:
- Chronic Pain
- Reduction of cancer cells
- Neurodegenerative diseases
- Auto-immune diseases
Currently, growers are experimenting with new breeding techniques to try and produce plants with larger traces of CBG. While CBG is currently a minor cannabinoid, the future is very bright.